The present invention relates to: a composition for diagnosing Alzheimer's disease, comprising a preparation for measuring the level of mRNA(s) of one or more genes selected from the group consisting of neurotrimin (NTM), peptidyl glycine alpha amidating monooxygenase (PAM), receptor type tyrosine protein phosphatase N2 (PTPRN2), opioid-binding protein/cell adhesion molecule (OPCML), 14-3-3 protein ζ/δ (YWHAZ), chromogranin-A (CHGA) and secretogranin-1 (CHGB), or the level of protein(s) expressed therefrom; a kit for diagnosing Alzheimer's disease, comprising the composition; and a method for providing information for the diagnosis of Alzheimer's disease, comprising the steps of measuring the level of mRNA(s) of the gene(s), or protein(s) expressed therefrom, and comparing the measured level with the level measured in a sample isolated from a normal individual. The composition for diagnosing Alzheimer's disease, of the present invention, enables Alzheimer's disease to be diagnosed with high sensitivity and specificity by the measuring of the expression level of the mRNA(s) of the gene(s), or the expression level of protein(s) expressed therefrom, so as to compare same with that of a normal control group.
BIOMARKER PROTEINS FOR DIAGNOSING ALZHEIMER'S DISEASE, AND USES THEREOF